Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining

Journal of Experimental Medicine

Volumn 195, Issue 5, 2002, Pages 625-636

  Gumperz, Jenny E ^a   Miyake, Sachiko ^b   Yamamura, Takashi ^b   Brenner, Michael B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Autoimmune disease; Cancer; Cytotoxic T cells; Lipid antigens; Th1 Th2 cytokines

Indexed keywords

CYTOKINE; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; IONOMYCIN; PERFORIN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGENICITY; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TUMOR REJECTION;

ANIMALS; ANTIGENS, CD1; ANTIGENS, SURFACE; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; GALACTOSYLCERAMIDES; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MICE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LYMPHOCYTE HOMING; STAINING AND LABELING;

EID: 0037018101     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011786     Document Type: Article

References (62)

1. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
2. + T lymphocytes
3. - T cells
4. + T cells produce large amounts of IL-4 and IFN-T-γ upon activation by anti-CD3 or CD1
5. + T-cell antigen receptor α chain in mice
6. - T cells in mice and humans
7. Diverse TCRs recognize murine CD1
8. + T cells in major histocompatibility complex class II deficient mice
9. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments
10. The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families
11. - and heterogeneous with respect to TCR β expression
12. - reactive T cells that can suppress mixed lymphocyte responses
13. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
14. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
15. + T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo
16. + T cells expressing NK cell receptors in influenza A virus-infected
17. + T cells
18. Murine CD1d-restricted T cell recognition of cellular lipids
19. Murine natural killer T(NKT) cells (correction of natural killer cells) contribute to the granulomatous reaction caused by mycobacterial cell walls
20. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceranrides
21. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
22. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse
23. + NKT cells associated with disease development in autoinimune-prone mice
24. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis
25. Requirement for Vα14 NKT cells in IL-12- mediated rejection of tumors
26. Cutting edge: Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide
27. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi
28. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD) mice by the influence of IL-4 and/or IL-10
29. Extreme Th1 bias of invariant Vα24JαQT cells in type 1 diabetes
30. α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
31. Natural killer T cell activation inhibits hepatitis B virus replication in vivo
32. + natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans
33. + NK cells in vitro
34. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
35. Phenotypic analysis of antigen-specific T lymphocytes
36. Expression of T cell antigen receptor heterodimers in a lipid-linked form
37. Synthesis of α-, β-monoglycosylceramides and four diastereomers of an α-galactosylceramide
38. Complexes prepared from protein A and human serum, IgG, or Fc-γ fragments: Characterization by immunochemical analysis of ultracentrifugation fractions and studies on their interconversion
39. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography
40. The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytotysis
41. Inhibition of human NK cell-mediated killing by CD1 molecules
42. Human NKK-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes
43. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
44. Immunization with α-galactosylceramide polarizes CD1-reactive NKT cells towards Th2 cytokine synthesis
45. The interface between innate and acquired immmnunity: Glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes
46. Cutting edge: Activation of NKT cells by CD1d and α-galacto sylceramide directs conventional T cells to the acquisition of a Th2 phenotype
47. + T cells
48. + natural killer T cells activated by α-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells
49. The natural killer T (NKT) cell ligand αs-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
50. Interleukin-12 activates NK cells for IFN-γ-dependent and NKT cells for lFN-γindependent antimetastatic activity
51. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
52. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages
53. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
54. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function
55. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells
56. Differential tumor surveillance by natural killer (NK) and NKT cells
57. + thymocyte population associated with intact Fas antigen expression on the target
58. Metalloproteinase-mediated release of human Fas ligand
59. Differential expression of NKT cell Vα24Jα Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy
60. Elevated proportion of natural killer T cells in periodontitis lesions: A common feature of chronic inflammatory diseases
61. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells
62. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes